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to the ensiform process. The routine radiological 
tests, liver function tests, blood examinations, 
etc., were all negative. At exploratory operation 
through a midline epigastric incision, a small 
cystic oval tumour was found in the attachment 
of the falciform ligament to the liver. The pa-
thologist's report was benign jibrolipoma: cystic 
degeneration, with elements of liver tissue in the 
walls of the cyst. 
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TRANSPLANTATION OF THE 
HUMAN LIVER Jd.4 ~* 
THOMAS E. STARZL ", 
LAWRENCE J. KOEP, 
In this chapter, the usual 
omitted of devoting a secti 
,a 
ground. The reason is t t the first report by 
Welch! of whole-or epa tic transplantation 
in animals was onl 23 ears ago. Furthermore, 
the first clinical attempts at liver transplanta-
tion were not made until 1963.2 Consequently, 
these as well as most of the other early articles 
on liver transplantation are still of current in-
terest. A complete bibliography of this subject 
through early 1969 is available in a recently 
published text, with ~ later upda~ through 
1975.' ~Kg I" J('f} • 
KINDS OF OPERATIONS 
Auxiliary Transplantation 
There are two general approaches to transplan-
tation of the liver. With one method, an extra 
liver is inserted at an ectopic site without re-
moval of the diseased native organ. This was 
the procedure that Welch! developed in dogs 
with the ultimate objective of treating patients 
who were dying of cirrhosis or other nonneoplas-
tic hepatic diseases. 
One technique used for auxiliary hepatic 
transplantation as adapted to human subjects 
is depicted in Figure 1. Here, the extra liver 
is placed in the right paravertebral gutter or 
right pelvis. Its hepatic arterial supply is de-
rived from the aorta or an iliac branch. Venous 
inflow is reconstituted by anastomosing the host 
superior mesenteric vein to the homograft por-
tal vein. Outflow is into the inferior vena cava. 
At first thought, the use of auxiliary homo-
grafts for the treatment of benign hepatic dis-
ease has a special appeal. First, sacrifice of the 
remaining, albeit limited, function of the failing 
recipient liver can be avoided. Thus, in the event 
of poor initial performance by the homograft 
due to ischemia or to a severe but reversible 
rejection, it might be hoped that some assistance 
would be provided by the diseased host liver 
during a transition recovery period. This would 
be predicted to be a particularly significant ad-
vantage in patients with biliary atresia, since 
the snythesizing functions of the liver are often 
retained until the terminal stages of this dis-
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ease. Second, it was assumed initially that the 
placement of an extra liver would be safer and 
technically less demanding than the orthotopic 
procedure. 
In actual practice, auxiliary transplantation 
has lost much favor. The results in animals have 
been inferior to those with liver replacement, 
partly because coexisting livers have the capac-
ity to damage each other to a variable degree, 
according to which organ is the "dominant" one. 
Factors favoring dominance include a splanch-
nic source of the blood for portal venous inflow, 
perfect biliary drainage, optimal total hepatic 
blood flow, and unimpeded venous outflow. An 
auxiliary canine liver graft, which does not en-
joy these advantages relative to the host liver, 
undergoes rapid atrophy by mechanisms that 
have been ascribed to "interliver competition." 
A detailed discussion of this fascinating topic 
has been published,· and the broader implica-
tions of splanchnic blood factors in controlling 
hepatic physiology and function has been the 
subject of a recent Ciba Foundation Sym-
posium.' 
Here, it will only be noted that most patients 
who would be candidates for liver transplanta-
tion do not have adequately functioning livers, 
so that the concept of competition may not be 
a critical one in clinical practice. Nevertheless, 
auxiliary liver transplantation for the indica-
" 
.. 
# 
FIG. 1. Technique of auxiliary liver transplantation 
that provides splanchnic venous flow for the homograft. 
Because of portal hypertension caused by the diseased 
native liver, splanchnic flow will pass preferentiall~ 
throuCh the homocraft. (From Starzl. Experience in Hepatic 
TroTUlpiantatio1l. Philadelphia. Saunders. 1969, p. 503.) 
tion of hepatic failure has resulted in the signifi· 
cant prolongation of life for only one patient. 
This was a child with biliary atresia who is still 
well as of April 1978, more than 6 years after 
auxiliary tranSplantation by Fortner,' using a 
technique similar to that shown in Figure l. 
The reasons for failure have been several. In 
many cases good initial homograft; function was 
not obtained due to an ischemic injury dur-
ing and after donor death. In others, the pres-
ence of an extra organ within the abdomen was 
not well tolerated with restriction of diaphrag-
matic movement and consequent lethal pulmo-
nary complications. Finally, the expectation 
that the placement of an extra organ would be 
technically simpler than with liver replacement 
has not been borne out by actual experience. 
as evidenced by an extremely high incidence 
of mechanical complications. Because of the 
poor clinical results, the number of attempts 
at human auxiliary transplantation has de-
clined to the point that this kind of operation 
will not be considered further in the rest of the 
chapter. 
Orthotopic Transplantation 
In contrast, there is mounting evidence that the 
operation of orthotopic hepatic transplantl;ltion 
Give, ",pla_ent) will play an ine,easT" 
---------
• 
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in the future treatment of liver disorders. With 
this procedure, the diseased host liver is re-
moved, creating a space into which a graft is 
transplanted with as normal an anatomic recon-
struction as possible. Survival in dogs and hu-
man subjects has been achieved exceeding 12 
and U~ years, respectively. The remarks in suc-
ceeding sections will pertain to orthotopic 
transplantation. 
PREOPERATIVE PREPARATION 
Virtually all prospective liver recipients are 
poor risks for a major operation, and many of 
those with hepatic failure from nonneoplastic 
diseases appear at first evaluation to be hope-
less. Symptomatic relief may be obtained by the 
performance of procedures such as paracentesis 
or thoracocentesis. But, unfortunately, there is 
probably little of real value that can be done 
to reduce the consequent operative hazards 
short of providing liver tissue. Nevertheless, 
even patients near death from complications of 
hepatic disease can be brought through the 
transplantation procedure with almost immedi-
ate improvement providing the homograft func-
tions properly and promptly. 
Although little can be done for the preexisting 
liver failure, secondary abnormalities of other 
organs can sometimes be effectively amelio-
rated. For example, the effects of renal failure 
secondary to the hepatorenal syndrome can be 
treated with the artificial kidney. Pulmonary 
manifestations may be improved by simple tra-
cheobronchial toilet, particularly if aspiration 
has occurred. Transfusions of blood or albumin 
may be useful for the correction of blood volume 
or other fluid space abnormalities. Iffresh whole 
blood, fresh frozen plasma, or platelets are judi-
ciously given, some improvement in coagulation 
may be possible. 
CASE SELECTION 
According to Underlying Disease 
Hepatic Malignancy. When orthotopic liver 
transplantation was first attempted in humans, 
primary liver malignancy was considered to be 
an outstanding indication for proceeding. Liver 
replacement was conceived of as a means of ex-
tending the limits of resectability in patients 
who did not have extrahepatic spread of their 
tumors. 
In actual experience, our results have been 
discouraging. About 80 percent of our patients 
who were treated in this way for hepatomas, 
intrahepatic duct cell carcinomas, cholangiocar-
cinomas, and sarcomas and who lived through 
the early postoperative interval developed tu-
mor recurrence.3,. Most commonly, the post-
transplantation metastases involved the new 
liver (Fig. 2). Deaths from recurrence have oc-
curred as early as 143 days (Fig. 2) and as long 
as 2 years after transplantation. a 
It is a bit too early to conclude once and for 
all that liver replacement in the face of hepatic 
malignancy is a futile undertaking. One of our 
patients, whose primary reason for liver trans-
plantation was biliary atresia, had an incidental 
hepatoma in the total hepatectomy specimen. 
Her preoperative serum contained almost 4 mg 
per dl of alpha fetoprotein. After operation in 
January 1970, the fetoprotein disappeared from 
the serum (Fig. 3) and has not recurred in the 
8lh years of posttransplantation life. Appar-
ently, this child has achieved a cure from her 
hepatoma. Another of our patients, a 45-year-
old man, is free of tumor 3lh years after liver 
replacement for a small intrahepatic duct cell 
carcinoma. Finally, a 28-year-old woman is well 
but with very slowly growing pulmonary metas-
tases Ilh years after transplantation for scle-
rosing cholangiocarcinoma. Palliation or even 
cure of primary hepatic malignancies has also 
been reported by CaIne et al.' 
Biliary Atresia. Nevertheless, the prime indi-
cations for orthotopic liver transplantation have 
come to be terminal liver diseases of nonneo-
plastic origin. Of these, extrahepatic biliary 
atresia is perhaps the least questionable, since 
death is inevitable after a relatively predictable 
interval and without any hope in the remaining 
life for rehabilitation. With intrahepatic biliary 
atresia, more conservatism is exercised, as some 
of these children can survive for many years. 
Other Benign Diseases. The problem of the 
proper time for liver transplantation may be 
a difficult one for almost all other kinds of non-
neoplastic liver disease. This is particularly so 
if alcoholism is a significant etiologic factor that 
could be eliminated by abstinence. Other com-
mon diseases in our series have been chronic 
aggressive hepatitis, inborn errors of metabo-
lism (Wilson's disease, alphal-antitrypsin de-
ficiency, Type 4 glycogen storage disease), 
sclerosing cholangitis, and primary biliary cir-
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FIG. 6. ""'Technetium liver !lCIU18 In a patient whose Indication for transplantation waa hepatoma. 
Note progressive Invaaion of liver homovaft by tumor beeinnlng at 94 days. The patient died of 
carcinomatosis 143 days posttransplantation. At autopsy, the homograft waa almost completely re-
placed with carcinoma. (From StanL Experience in Hepatic Transplantation. Philadelphia, Saunders, 1969.) 
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TIME IN MONTHS 
rhosis. The time to proceed is when the patient 
is socially and vocationally invalided, or cannot 
live longer outside the hospital. Patients with 
acute liver disease are usually not considered 
since they have the capacity to recover sponta-
neously. Contraindications would include ad-
vanced age (probably above 50 years), a history 
of sociopathic behavior that would prevent post-
operative management, preexisting and un-
treatable systemic or local infections, or serious 
disease of organs other than the liver, as, for 
example, with coexisting severe heart disease. 
FIG. 3. Alpba·fetoproteln determinations In a 3-yeal'-
old child who underwent transplantation for biliary 
atresia. A small hepatoma waa discovered within the 
operative 8pecimen. The child is now 3% years after 
transplantation. Alpha·tetoproteln determinations con-
tinue to be negative and she remains free of tumor. 
According to Immunologic Criteria 
ABO Matching and Cytotoxic Antibodies. When 
possible, the rules of tissue transfer are followed 
(Table 1). These are designed to avoid the 
transplantation of an organ into a recipient who 
possesses preformed antidonor isoagglutinins. 
Violation of these guidelines in kidney trans-
plantation can lead to immediate graft destruc-
tion by hyperacute rejection. The liver has 
proved resistant to this complication, meaning 
that blood group· barriers can be breached in 
, 
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Direction of Acceptable Mismatched 
Tissue Transfer 
o to non-O· 
Rh- to Rh+ 
Rh+ to Rh-
A to non-A 
B to non-B 
AB to non-ABt 
• 0 is univenral donor. 
tAB is univenral recipient. 
Safe 
Safe 
Relatively safe 
Dangerous 
Dangerous 
Dangerous 
the case of desperate need.4 Even more surpris-
ingly, the presence of preformed cytotoxic anti-
bodies against donor tissues does not usually 
cause hyperacute liver rejection.· 
HL-A Matching. The poor correlation in renal, 
cardiac, and liver transplantation between 
HL-A matching and clinical outcome has led 
us to ignore the question to HL-A matching for 
liver transplantation. Nor do we even use the 
most favorable matching as an instrument of 
selection amongst a given group of candidates 
for transplantation. At the present, our major 
criterion concerns who has the most pressing 
need. 
DONOR PROCUREMENT 
One of the important advances in transplanta-
tion has been social in nature, consisting of ac-
ceptance by the public of the concept of cadav-
eric organ removal. In the United States and 
many other countries, this acceptance has led 
to a sharpening and liberalization of the criteria 
of death in accordance with the concept of irre-
versible brain injury. Ifbrain death is accepted, 
one of the most serious problems in organ 
transplantation is virtually eliminated, since 
the interval of normothermic ischemic injury 
subsequent to cardiac arrest is reduced essen-
tially to zero inasmuch as the dissection prior 
to the removal of the liver or other organs can 
be carried out or even completed in the presence 
of an effective circulation. 
With the advantages conferred by the accep-
tance of brain death, it is possible to maintain 
a well perfused liver in situ up to the moment 
of its excision. After removal, human livers can 
be preserved for as long as 12 hours by infusing 
them with specially prepared cold solutions.··· 
These recent developments have permitted the 
shipment of preserved livers from city to city 
and have relieved some of the problems of organ 
supply. 
OPERATIVE PROCEDURES 
Donor Hepatectomy 
The essential feature of liver removal is ex-
tremely straightforward and consists of skele-
tonization of the structures entering and leav-
ing the liver. Frequently, the first step upon 
entering the abdomen and after examining the 
liver is incision of the restraining ligaments of 
the liver. The falciform ligament is divided 
down to or near the entry of the hepatic veins 
(Fig. 4). The left triangular ligament is incised 
(Fig. 5), as well as the right triangular and coro-
nary ligaments (Fig. 6). 
It is partiCUlarly important in freeing the 
right lobe of the liver from the bare area that 
the dissection be carried out sharply. Otherwise, 
subcapsular hematomas or capsular tears may 
be caused inadvertently. As the right lobe of 
the liver is rotated into the wound with expo-
sure of the bare area, the right adrenal vein 
is readily identified entering the vena cava be-
hind the liver (Fig. 7); this vessel is ligated and 
and divided. After clearing loose areolar tissue 
away, it is usually possible to sweep behind the 
vena cava from the diaphragm to the entry of 
the renal veins without resistance (Fig. 8). 
The rest of the dissection of the donor liver 
consists in isolating the structures below the 
liver as depicted in Figure 9. Usually the hepatic 
artery is dissected back to its origin from the 
celiac axis, ligating its gastroduodenal and right 
gastric branches (Fig. 9A and B). A long segment 
of the portal vein is similarly freed inferiorly 
to at least the entrance of the splenic vein (Fig. 
9C). In many cases, the biliary drainage proce-
dure ofcholecystoenterostomy is planned. If this 
is contemplated, the common duct is ligated be-
low the entrance of the cystic duct and an inci· 
sion into the gallbladder is made so that the 
bile may be washed out. In experimental ani-
mals, failure to observe this precaution may 
lead to autolysis of the extrahepatic biliary duct 
system during the time when the organ is with-
out a circulation. 
The final step in the removal of the liver is 
further development of the cuff of vena cava 
above the liver into which empty the main he-
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Right 
lobe 
f 
FIG.4. Initialateps In donor hepatectomy. (From Starzl. Experience ill Hepatic TranspwntatiolL Philadel. 
phia. Saunders. 1969.) 
FIG. 6. Donor hepatectomy (continued). Exposure and the initial cHasection ot the auprahepatic vena 
cava and Ita tributariea. Alter enterln, the raw area formed by divergence ofthe leaves ofthe talcllorm 
and trlancuIar U,amenta, a ahort llefJDent ot the left hepatic vein (L.H.V.) la 1UUally aeen ftrat. (From 
Slarzl. Expemru:e in Hepatic TransplantatiolL Philadelphia, Saunders, 1969.) 
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FlG. 8. Donor hepatectomy (continued). Incision of the 
clirht triangular ligament and the anterior leaf olthe clirht 
coronary lilfament. (From Stanl. Experience in HepatU: 
Tran8plantatiolL Philadelphia. Saunders. 1969.) 
Adrenal 
gland 
R.H.v. 
Right 
triangular 
Ii g. 
FlG. 1. Donor hepatectomy (continued). The liver is retracted to the left, openinl the hare area of 
the rilfht hepatic lobe and expoam, the adrenal ,land. The clirht adrenal vein is Ilcated and divided. 
This is uaually the only poaterior tributary to the retrohepatic vena caVL At this stale. the richt 
hepatic vein (R.H. V.) can be identified. (From Stanl. Experience in HepatU: 7huispiantatiolL Philadelphia, 
Saunders, 1969.) 
• 
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FIG. 8. Donor hepatectomy (continued). After ligating the right adrenal vein (R.a.v.), it should be 
possible to sweep the finger behind the retrohepatic vena cava from the diaphragm to the renal 
veins. If resiBtance is encountered, it llBUalIy indicates the presence of extra branches which must 
be ligated and divided. (From Starz\. bxpt!rie~ in Hepatic 1'ran8plantation. Philadelphia. Saunders. 1969.) 
patic veins (Fig. 10). This segment of vena cava 
is extremely short and is actually a confluence 
of vessels to form a venous cloaca. When the 
vena cava is finally transected and one peers 
into the liver side of this cloaca, the view is 
as shown in Figure 10 (inset). 
With removal of the liver, infusion with a 
chilled solution is carried out via the portal vein 
(Fig. 11). In addition to cooling the organ, blood 
is washed out, thereby facilitating the anasto-
moses which can be performed in a clean field. 
There have been a number of infusion fluids 
recommended ranging from simple electrolyte 
solutions to the elaborate concoctions that have 
allowed longer preservation.8•11 
The Recipient Operation 
Most of the steps in the recipient are identical 
or similar to those described above under the 
donor except that the long cuffs are left with 
the patient rather than with the homograft. 
After removal of the liver, the usual anatomy 
consists of cuffs offour vessels, the common duct 
stump (except in biliary atresia), and the raw 
areas left by incision of the various hepatic liga-
ments (Fig. 12). The reconstruction consists of 
anastomosing the individual vessels to the com-
panion vessels of the homograft as quickly as 
feasible. The "standard" operation is shown in 
-Figure 13. 
One feature of the vascular reconstruction 
that is a special one in liver transplantation 
is the necessity to perform some of the vascular 
anastomoses in cramped quarters and with 
short vessel lengths. To permit this kind of anas-
tomosis, intraluminal suturing techniques have 
been developed (Fig. 14), in which the principle 
is the formation of shoulders of venous wall pos-
teriorly with systematic eversion. a This has 
sometimes been done with a double posterior 
layer (Fig. 14) or more recently a single everting 
layer has been employed. 
Various biliary reconstructions that we have 
used are shown in Figure 15. Ifpossible, choledo-
chocholedochostomy is performed (Fig. 15D). 
The first alternative is cholecystojejunostomy 
to a Roux limb, realizing that conversion to cho-
ledochojejunostomy may be necessary at a sec-
ondary operation. If the gallbladder is not in 
perfect condition or if the cystic duct enters the 
common duct at an anomalously low level, the 
gallbladder is removed and primary choledocho-
jejunostomy is performed. We no longer do cho-
lecystoduodenostomy (Fig. 15A) because of a 
high incidence of cholangitis and because there 
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FlG. II. Donor hepatectomy (continued). Dissection of the portal triad. A. The ,utroduodenal and 
ri,ht ,ulric arteries are tied off and divided. Before ligatin, the common duct, it should be determined 
that It communicates freely with the gallbladder via the cystic duet. B. The hepatic artery is mobilized, 
uneoverine the anterior surface of the portal vein. The coronary vein entering the left side of the 
portal trunk is almost always found; this tributary is li,ateci and divided. C. Mobilization of the 
cellac ana. The splenic artery has not yet been ligated and divided. The entire celiac azia is usually 
retained with the homograft. (From Stanl. Experience in. Hepatic Transplantation.. Philadelphia, Saunders, 
1969.) 
have been too many problems with the duode-
num when secondary conversion to choledo-
choenterostomy became necessary. 
Technical Difficulties and Dangers 
Hemorrhage. Acute bleeding can be particu-
larly troublesome during the actual liver trans-
plantation because of the portal hypertension 
that is present in nearly every patient. During 
the operation, the usual sequence is mechanical 
bleeding that can rapidly assume nightmare 
proportions if a severe coagulation disorder su-
pervenes. Many of the normal coagulation fac-
tors that might help control hemorrhage are 
dependent on the liver and are, therefore, defec-
tive to begin with in the diseased recipient. 
These coagulation deficiencies may become rap-
idly worse after revascularization of an organ 
which has suffered ischemic damage, appar-
ently because of consumption of clotting factors 
by the injured graft. 4 
When hemorrhage occurs, all mechanical he-
mostatic tactics including ligature, suture, and 
cautery are used until the revascularized homo-
graft can participate in what is hoped will be 
appropriate coagulation function. In our early 
patients, an attempt was made to treat such 
bleeding problems by administering thrombo-
genic agents such as epsilon amino caproic acid 
(EACA). Lately, we have studiously avoided 
such practices for reasons to be discussed later. 
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FIG. 10. Donor hepatectomy (continued). Dissection above the liver. A. Development of luprahepatic 
vena caval cuJr. A longer caval segment for aubeequent anaatomOflia may be obtained by Ugating 
and dividing one or more phrenic veins on each aide and by diaaectin.g oft the diaphragmatic reflection, 
88 shown. B. (1naet) The c!'Oll!HleCti.onal appearance of the venoUl confluence above the liver, 88 seen 
from above. The venous cloaca b formed by the junction of the right and left hepatic veina with 
the inferior vena cava. (From Stanl. bxpett~ in eepo~ Tran.splantation. Philadelphia, Saunders, 1969.) 
1000 cold lactated J:hnQal'"S 
with 1 Qram procain~ chloride 
FIG. 11. Perfusion of the exciaed homocraft with. 
chilled electrolyte solution iDfu8ed through a catheter 
inaerted into the portal vein. For 10lller preaervatioD. 
special 8OIutiollll are iDfu8ed after the Initial flushing. I .1 
(From Stan!. Surr Gyn«:ol Ob6tet 117:6119, 1963.) 
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FIG. J£ Recipient operation. The operative field after removal of the diseased hoet liver. A bilateral 
subcostal Incision is UBUally WIed with a right thoracic or xiphoid extension if required (see FiI. 
18). 
.! 
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FIG. 13. Standard operation. In children with billary atn.ia. and often In adult. whose common 
duet will not reach the proper position at the homoeraft., biliary reconstruction is to an IS-Inch Rous-
en-Y Umb of jejunum (eee Fig. IS). (From Stanl. Experience in Hepatic TralUlplantation. Philadelphia, Saun-
ders 1969, p 138.) 
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FlG. U. Intraluminal IUturln( technique for the performance of the ,uprahepatic vena caval IlIl8Ito-
mOlia. The poaterior row may be , .. bloned In two layen from within the lumen, but recently a 
Iinlle layer evertlnl technique baa been employed. (From Stanl. Surg Gyn«ol Obstet 117:659, 1968.) 
Instead, complete dependence is placed on natu-
ral processes for correction ofthe abnormalities. 
In adults with cirrhosis, it has been possible 
to reduce hemorrhage by avoiding dissection in 
the bare area or above the liver until the hilar 
structures are divided. When everything is 
ready, the inferior vena cava is transected. Then 
by pulling on clamps that are placed on the he-
patic side of these structures, the liver is dis-
sected free from below to above, ligating all cut 
tissues on the way (Figs. 16, 17). The suprahe-
patic inferior vena cava remains intact as the 
stalk of the specimen until it is clamped just 
before the liver is removed. This variation in 
operation has been particularly useful in devel-
oping a reasonably long suprahepatic cu1f of the 
inferior vena cava in adults. The vena cava or 
FlG. lIS. TechniquN of biliary reconatruction. Cho&. 
cywtoduodenoatomy rAJ" no lonler used <tee text). <From 
Stanl. Surg GyMCOI Obstet 142:.a7, 1976.) 
main hepatic veins may be dissected free from 
within the cirrhotic liver in a bloodless field 
(Fig. 17B). 
Anesthesia Problems. The complexity of an-
esthetic management during liver transplanta-
tion is increased by the fact that the procedure 
is long, difficult, and often bloody. Even more 
importantly, it is an operation on the primary 
organ involved in the metabolism and detoxifi-
cation of most common anesthetics. The task 
of the anesthesiologist is to administer correctly 
drugs that, first, are not hepatotoxic and, sec-
ond, do not depend primarily on the liver for 
their degradation. In our cases, reliance bas 
been placed mainly on combinations of volatile 
agents in nonexplosive concentrations. Such 
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adrenal Y. 
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nG. 16. Technique of retrof1"8de removal of liver. A. 
Incisioll8. AA. Subcosta1incislon used for all orthotopic 
liver transplantations. BB, a:; DD. Frequently used es-
tensions from the AA incision. B. Beiinnlng retrograde 
removal after transection of inferior vena cava and hilar 
structures. All posterior tissue that is cut .hould be li-
gated, although the named vesseis encountered, such 
88 the right adrenal vein, are few in number. (From StanJ.. 
Surg Gynecol Obsut 142:487. 1976.) 
management permits use of the electrocautery, 
gives Bexibility in lightening or deepening an-
esthesia, and allows anesthesia to be abruptly 
stopped if required by changing physiologic cir-
cumstances. 
A number of swiftly changing metabolic con-
ditions have to be carefully scrutinized during 
the anhepatic phase and immediately after-
ward. Since the patient is at risk from acute 
hypoglycemia, a constant infusion of glucose is 
required, and for proper control of the situation 
frequent blood sugar determinations must be 
obtained. At the same time, the majority of re-
cipients develop some element of acute meta-
bolic acidosis, also requiring monitoring and 
correction. A third life-threatening complica-
tion that has been frequently seen just after 
revascularization and lasting for several hours 
nG. 17. A. Operative field after retrof1"8de liver mobili-
zation. The last remaining structure, the suprahepatic 
inferior vena cava, has been clamped above the liver. 
B. Technique for mobilizing a sultable lenitth of suprahe-
patic vena cava after placement of clamp. In adults, tb.ia 
usually involves cutting away cirrhotic liver tissue over 
the frequently distorted and foreshortened right and left 
hepatic veins. (From StanJ.. Surg Gynecol Obsut 142:487. 
1976.) 
is hypokalemia. Apparently, the potassium is 
sequestered in the grafts to the extent that se-
rum potassium concentrations as low as 1.5 mEq 
per liter have been observed. 
Spatial Problems. Not surprisingly, a homo-
graft of exactly the right size may be difficult 
to find for any given recipient. Consequently, 
major size disparities often have had to be ac-
cepted. There have been few difficulties in using 
undersized organs. For example, it has been p0s-
sible to carry out orthotopic transplantation of 
a 5-year-old liver to a full-sized adult. Other size 
mismatches nearly as extreme have been 
safe. 
On the other hand, serious risks are borne 
when the donor organ is disproportionately 
large. Size disparities in this direction may lead 
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to compression of the blood supply. This kind 
of complication tends to occur just as the abdo-
men is being closed, in which case an adverse 
chain of events leading to death may be set in 
motion, but not appreciated, until it is too late 
for correction. 
Vascular Anomalies. Anatomic variations of ei-
ther the graft or host arteries have been encoun-
tered in almost 40 percent of our cases. Multiple 
arteries have been the most frequent anomalies. 
When these have been found in the recipient, 
most commonly the graft celiac axis has been 
connected to the host celiac axis. When the mul-
tiplicity has been ofthe transplant vessels, mul-
tiple arterial anastomoses or other variant pro-
cedures have been used. Unquestionably, the 
need to improvise in these situations imposes 
an extra risk, particularly in the very young 
recipients whose arteries are quite small and 
thin-walled. In patients with biliary atresia, 
anomalies may be encountered of which the 
complexity may be so great as to make it virtu-
ally impossible to succeed. 
Other Operative Problems. A long list of other 
technical pitfalls aside from biliary duct prob-
lems has been accumulated.3•4 These include 
vascular thrombosis, crushing of the phrenic 
nerve(s) at the diaphragm, adrenal infarction 
secondary to sacrifice of the right adrenal vein, 
and air embolism. Early in our experience, air 
emboli caused crippling neurologic injury in 
about 20 percent of our adult recipients. The 
Low mo .. tular ."91'11 
CI,.I Ie.) 
, 
c. 
Inffol'l.potlc OIIOltOMO'l' 
\..ivet" 
---... , ~~- ------
best evidence is that the air came from the ho-
mograft itself, passed around the lungs via large 
right to left collaterals that are well developed 
in chronic liver disease, and passed to the 
brain. 10 The complication has been eliminated 
with the flush-out technique shown in Figure 
18. 
NONIMMUNOLOGIC 
POSTOPERATIVE 
COMPLICATIONS 
In 1975 and 1976, complete clinicopathologic 
correlations were made in the first 100 cases 
of orthotopic liver transplantation. The objec-
tive was to determine the reasons for success 
or failure in every case. The perspective that 
emerged was different from that generally held, 
in that the most important lethal problems were 
non immunologic in nature. The main reasons 
for death were technical and mechanical and 
were responsible for about half of the ultimate 
mortality. 
The inception offatal complications was often 
traceable to some of the intraoperative compli-
cations mentioned earlier. The starting point 
of recovery was flawed in other instances by 
the use of severely damaged organs, suboptimal 
vascularization procedures leading to later por-
tal vein or hepatic artery thrombosis, and leav-
ing a nidus for subsequent intraabdominal in-
fection. There was also a high incidence of 
gastrointestinal hemorrhage and perforation of 
FIG. 18. Technique to prevent air emboUam from ortho-
topic Over homoerafta. A ContinuoWl perfusion ollOlu-
tiOD throurh portal vein .. vena caval anastomoses are 
coMtructed. A C Escape 01 air bubbles .. the anasto-
moses are completed. (From Starz!. '(""Su'6'l87:236, 1978.) 
" 
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FIG. 11. An explanation lor the predisposition 01 the 
liver to bacterial and fun,alllepllia. Pre8umably the In-
vadln, microorranlama enter throu,h the reconatructecl 
biliary tract. <From Star&l. Ann Surg 168:392. 1968.) 
viscera (especially the colon). Analyses of these 
calamities have been published."· 
The Special Role of Biliary 
Complications 
However, the leading cause of delayed death 
stemmed from faulty biliary tract recon-
struction. _.11 For example, in the first 93 consec-
utive cases there were 24 examples of biliary 
obstruction and 8 of bile fistula formation. Reop-
eration was attempted in only half of these pa-
tients and even then, attempts were almost uni-
formly unsuccessful. In most of these early 
patients, the method of biliary reconstruction 
had been with cholecystoduodenostomy (Fig. 
15A) from which stemmed a very high inci~ence 
of cholangitis. Conversion of cholecystoduode-
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FIG. .. The coune 01 a patient who had triple dru, ther-
apy with cyclophOlphamide (lnatead 01 azathioprine)' 
prednisone, and hone ALa. Note that there was excellent 
liver function except durin, the IIeCOnd and third postop-
erative montha, when the patient developed jaundJce and 
n- In the levels 01 the 8erWIl tranaamin-. TheBe abo 
normalitiee were coincidental with the appearance 01 the 
Australia anti(en In the aerum. and conaequenUy were 
probably reftectiona ol8erWll hepatitis rather than rejeo-
tion. The recipient'. orillnal diapOIiI was Wilson', dUo 
eaae. He iI well 7 yean after tr8D8plantation. 
nostomy to choledochoduodenostomy proved un-
satisfactory since it carried a high incidence of 
duodenal fistula, and did not uniformly relieve 
the cholangitis. The contamination of the liver 
became the starting event of systemic sepsis in 
which organisms indigenous to the gastrointes-
tinal tract (including Candida albicans) lodged 
in other locations (Fig. 19). In addition, there 
were multiple other causes of hepatic dysfunc-
tion such as serum hepatitis (Fig. 20), cytomega-
lovirus (CMV) infection. and possibly azathio-
prine toxicity. 
In retrospect, the mistake that had been sys-
tematically made was to ascribe postoperative 
homograft. dysfunction invariably to rejection 
and to respond therapeutically by intensifying 
immunosuppression. Therefore. reforms were 
instituted of two kinds. First, cholecystoduode-
nostomy was abandoned as a primary procedure 
in favor of choledochocholedochostomy, chole-
cystojejunostomy, and choledochojejunostomy 
(Fig. 15 BCD). 
Equally important was a vigorous diagnostic 
postoperative approach whereby repeated biop-
sies and intrahepatic cholangiography were per-
formed. Immunosuppression was then planned 
on the basis of the findings. The greatest divi-
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FIG. 31. Transhepatic cholangiolfr8,lD8 in folU patient. whoee oril(inal biliary recoll8tructiona were 
with oouKx~n·v cholecystojejUDostomy. A. depicted in (A), minimal obstruction; (8), moderate obetruc> 
tion; E~ severe obstruction with leak and a~ formation; (D), vel')' severe obstruction. At reopera-
tion the common duct was necrotic. (Key to abbreviationa: A = leak and abeceee formation; C = common 
duct; CD = cy.uc duct; GB = ,allbladder; J = jejunum; Iarce arrow = ute of common duct Illation. 
(From Stanl. Surgery U1:~1OI 1977.) 
dend has been the detection of biliary duct com-
plications. In Figure 21 are shown examples of 
obstructed duct systems after cholecystojejunos-
tomy. Stenosis was almost always found at or 
near the cystic duct. This complication has been 
easy to manage by converting cholecystojejunos-
tomy (Fig. 15B) to choledochojejunostomy (Fig. 
15C) by the technique shown in Figure 22. At 
reoperation, the gallbladder is removed, the end 
of the jejunal loop is closed, and the now dilated 
common duct is sutured to the side of the Roux 
limb. Stents are usually not nt:CeSSarY. After 
this reoperation, the wounds are broadly 
drained by leaving the central portion of the 
incision open. 
The reintervention is life saving (Fig. 23). 
With relief of partial obstruction bacteremia, 
fever and jaundice are relieved promptly and 
most such patients have recovered rapidly with 
appropriate antibiotics. An argument could be 
made to avoid this two-stage approach by per-
forming primary choledochojejunostomy and 
this hai, in fact, been done on a number of occa-
sions. However, the anastomosis of the small, 
normai duct of the homograft to a jejunal loop 
may be difficult. especially in children. As a con-
sequence, primary choledochojejunoetomy has 
been reserved for cases in which the gallbladder 
is unsatisfactory. 
MOst of the biliary fistulas we have seen have 
• • a 
A. 
InC'IIOft 1ft 
"'010 / 
./ 
E. 
FIG. 4 Technique of choledochojejun08tomy. (From Stanl. 8urget:y 81:212. 1977.) 
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been after choledochocholedochostomy." These 
can be managed effectively by wide drainage 
of the wound. T tubes have been left in place 
for as long as two years and as short as one 
month. It is probable that endoscopic retrograde 
cholangiography should be routinely used in the 
postoperative evaluation after the T tube has 
been removed. With the foregoing diagnostic 
and technical changes, deaths from biliary tract 
complications have been almost eliminated. 
IMMUNOSUPPRESSION 
The therapeutic regimens used in liver recipi-
ents have been the same as those evolved in 
kidney transplantation recipients. 
Double Drug Therapy 
Azathioprine and the synthetic adrenal cortico-
steroid, prednisone, are used together from the 
day of operation. This treatment protocol is pre-
ferred by CaIne' and has been used by us on 
a number of occasions. 
Triple Drug Therapy Including ALG 
In our center, most patients have had antilym-
phocyte globulin (ALG) as an adjunct to aza-
thioprine and prednisone. Antilymphocyte glob-
~ 
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FlG. M. The preparatlon 01 horae heterolocoU8 anti-
lymphocyte Ilobulin lor UIe in patlent-. <Ftom Stan!. 
ChriswpMr'. futbook of Surge".. Philadelphia, Saunders, 
1968.) 
ulin (ALG) is purified from the serum of horses 
or rabbits that have been immunized against 
human lymphoid tissue (Fig. 24). When injected 
intravenously the ALG inactivates or kills recip-
ient lymphocytes. The way in which the three 
agents are used together is shown in Figures 
23 and 25. If azathioprine toxicity is suspected, 
cyclophosphamide can be substituted (Fig. 20). 
The manifestations of rejection consist of the 
t! 
.- ... 
-• II) 115 10 • 
DAYS 
Fla JIll. The eourae 01 a patlent who underwent a rejection cri8U while under treatment with a 
triple drug procram that included IWlthloprlne, pred.nUone, and ALG. The rejectlon beran on the 
ehth ~yK reached a peak within 2 da,.., and receded promptly. Gram-nelfatlve bacteremia was cHar-
nOled from a blood apeclmen obtained on poeHransplantatlon day 14. Note that the immunoeuppre.ift 
therapy was actually U,htened with the development and evolutlon 01 the rejection criaII. 
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TABLE a. Fifty Adult Patients Treated by Liver Transplantation from March 1963 to July 1976 
(Follow-up to April 15, 1978) 
DIAGNOSIS 
Malignant tumort 
Chronic aggressive hepatitis 
Alcoholic cirrhosis 
Primary biliary cirrhosis 
Secondary biliary cirrhosis 
Sclerosing cholangitis with ulcerative colitis 
Massive hepatic necrosis due to hepatitis B virus 
Budd-Chiari syndrome 
Congenital biliary hypoplasia 
Total 
No. 0' 
ExAMPLES 
13 
17 
11 
4 
1 
1 
1 
1 
1 
50 
SURVIVAL 
(l yr) 
No. (%) 
2 (15) 
5 (30) 
1 ( 9) 
o ( 0) 
o ( 0) 
o ( 0) 
o ( 0) 
1 (100) 
1 (100) 
10 (20) 
AuvENow· 
1 (42 mo) 
1 (30 mol 
1 (48 mol 
o 
o 
o 
o 
1 (41 mo) 
1 (26 mol 
5 
• The 5 deatlt. a{Ur one year ocx:urred after 13*. 15*. 19. 20*. and 25 month&. 
t TIu!se include 1 hepatoma&. 4 duct cell carcinomas. 1 cholangiocarr:inoma, and 1 hemongioendothelial sarcoma. The patient 
who iI still alive hod a ST1&411 obstructing duct cell carcinoma. 
full range of liver malfunction (Fig. 25), includ-
ing jaundice, elevations of serum transaminase 
(indicating necrosis), and failure of synthetic 
functions. However, as pointed out earlier, these 
pertubations are not pathognomonic. Conse-
quently, the diagnosis of rejection must be one 
of exclusion_ Once all other possibilities have 
been ruled out, rejection is usually treated by 
intensification of steroid therapy. In a few re-
cent cases, thoracic duct drainage has been in-
stituted for lymphocyte depletion at the time 
of unmanageable rejection. 
CaIne? and wes have found uncontrolled rejec-
tion to be less of a problem than was originally 
anticipated, possibly because the liver is less 
vulnerable than other organs to immunologic 
attack.· Nevertheless, inadequate control of re-
jection remains a significant problem and has 
directly accounted for the death of about a quar-
ter of our recipients. 
RESULTS 
Early Cases 
Between March, 1963, through July, 1976, 111 
consecutive patients were treated by liver re-
placement. Thirty-one (28 percent) lived for as 
long as a year, and as of April 15, 1978, 15 are 
still alive after 26 to 99 months. Of the 111 pa-
tients, 50 were more than 18 years old; 10 of 
the 15 lived for at least a year (Table 2), and 
5 are still alive after 26 to 48 months. The 5 
late deaths occurred after 131h to 25 months 
(Table 2). 
The other 61 patients in the original series 
of 111 were 18 years of age or younger with 
the most common diagnosis being congenital 
biliary atresia (Table 3). Twenty-one (34 per-
cent) of these patients lived for a year and 10 
are still alive after 41 to 99 months. In this 
group, 7 patients have lived more than 5 years 
and all but one are still alive. 
In the original combined adult/pediatric se-
ries, 10 patients have lived more than 4 years 
and 9 are still alive. 
Recent Cases 
After the improvements in technique and man-
agement were instituted that were described 
earlier, an additional 30 consecutive patients 
were treated with liver replacement (Table 4). 
Fifteen of the 30 are alive with follow-ups of 3 
to 20 months; 14 of the 15 survivors are already 
more than 6 months postoperative and 9 have 
passed the one-year mark. All of the 15 survi-
vors are living outside the hospital. From this 
latest series it appears that the survival of both 
adult and pediatric recipients will be doubled 
compared to the results achieved before 1976. 
CaIne and Williams? and their associates from 
England have noted a similar, recent encourag-
ing trend. 
FUTURE PROSPECTS 
It is probable that the one-year survival after 
liver transplantation cannot be brought much 
• 
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TABLE 3. Sil:ty-one Pediatric Patients Treated by Liver Transplantation from March 
1963 to July 1976 (Follow-up to April 15, 1978) 
SURVIVAL FOLLOW-UP PREsENT 
TOTAL 
(1 yr) SURVIVORS-
DIAGNOSIS No. No. (%) No. Months 
Congenital biliary atresia 42 12 (29) 6 41,54,62,74,81,99 
Chronic aggressive hepatitis 10 3 (30) 2 41,50 
Hepatoma 3 2 (67) 0 -
Wilson's disease 2 2 (100) 1 85 
Congenital biliary cirrhosis 1 1 (100) 1 70 
Alpha1-antitrypsin deficiency 1 1 (100) 0 -
Tyrosinemia 1 0 (0) - -
Giant cell hepatitis 1 0 (0) - -
• Eleven other patients died a~r 12lh. 13. 13lh. 14. 17, 20. 26. 28. 30. 41. and 72 months 
TABLE 4. Adult/Pediatric Diviaion of 30 Cases 
August 1976 to December 1977 (Follow-up to April 
15, 1978) 
No. OF 6Mo 1 YEAR 
ExAMPLES .ALIVB POSTOP P087'OP 
Adults 18 8 (44%) 
Pediatric 
«18 yr) 12 7 (58%) 
over 50 to 60 percent without major advances 
in immunosuppression. Even though rejection 
has been uncontrollable in only about one-
fourth of our patients, the need for long-term 
high dose steroid therapy imposes life threats. 
How to achieve less toxic immunosuppression 
and earlier graft acceptance is still an unre-
solved dilemma. Wider use of thoracic duct 
drainage instituted at an earlier time may prove 
to be useful. 
Even with the present limitations ofimmun<>-
suppression, liver transplantation has slowly 
evolved in the last 15 years to a position of lim-
ited therapeutic value as opposed to an experi-
mental undertaking. The achievement of 7 sur-
vivors beyond the 5-year mark in our own series 
and the high quality of life being pursued by 
6 of these patients constitute proof of the poten-
tial of both the present value and futUre poten-
tial of liver replacement. 
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